NEW YORK (GenomeWeb News) – Bio-Rad Laboratories said today that it intends to transfer its stock from the American Stock Exchange to the New York Stock Exchange on or around Oct. 24.
 
The firm’s Class A common stock will continue to trade under the ticker BIO, and its Class B common stock will continue to trade under the ticker BIOb.
 
Bio-Rad President and CEO Norman Schwartz said in a statement that the firm’s shareholders “will benefit from the NYSE’s brand, reputation, and trading efficiencies.”

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.